Chiron Investment Management LLC Takes $3.55 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

Chiron Investment Management LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to its most recent 13F filing with the SEC. The fund purchased 8,729 shares of the company’s stock, valued at approximately $3,548,000.

A number of other hedge funds have also recently made changes to their positions in the company. Terra Nova Asset Management LLC lifted its holdings in shares of HCA Healthcare by 0.3% during the 3rd quarter. Terra Nova Asset Management LLC now owns 8,112 shares of the company’s stock worth $3,297,000 after acquiring an additional 26 shares during the last quarter. Massmutual Trust Co. FSB ADV lifted its holdings in shares of HCA Healthcare by 7.4% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 421 shares of the company’s stock worth $171,000 after acquiring an additional 29 shares during the last quarter. Waldron Private Wealth LLC lifted its holdings in shares of HCA Healthcare by 1.8% during the 3rd quarter. Waldron Private Wealth LLC now owns 1,681 shares of the company’s stock worth $683,000 after acquiring an additional 29 shares during the last quarter. Brookstone Capital Management lifted its holdings in shares of HCA Healthcare by 0.7% during the 3rd quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after acquiring an additional 30 shares during the last quarter. Finally, UMB Bank n.a. lifted its stake in HCA Healthcare by 2.4% in the third quarter. UMB Bank n.a. now owns 1,301 shares of the company’s stock worth $529,000 after purchasing an additional 30 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 8,358 shares of the company’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. This represents a 21.97 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,155 shares of company stock valued at $5,608,990. 1.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. StockNews.com downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and lowered their price target for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Royal Bank of Canada boosted their price target on shares of HCA Healthcare from $378.00 to $405.00 and gave the stock an “outperform” rating in a research note on Friday, August 23rd. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Finally, Raymond James downgraded shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus target price of $380.29.

HCA Healthcare Price Performance

Shares of HCA opened at $316.78 on Wednesday. The firm has a 50-day simple moving average of $362.09 and a two-hundred day simple moving average of $358.91. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a 1-year low of $255.73 and a 1-year high of $417.14. The stock has a market cap of $80.24 billion, a PE ratio of 14.22, a P/E/G ratio of 1.23 and a beta of 1.63.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date is Friday, December 13th. This represents a $2.64 annualized dividend and a dividend yield of 0.83%. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.